chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: itchy rash; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Mar2021 at 15:15 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any vaccination in four weeks. The patient did not receive any other medications in two weeks. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced broken out in an itchy rash since getting the vaccine. The rash was found on part of the face, part of the arm and around hip girdle. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient received treatment for the event. The clinical outcome of the event broken out in an itchy rash was not resolved at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pain in extremity, Pain of skin
Clinical narrative: Day 2 fever of 101 degrees F; severe chills; body aches; skin tenderness; Extreme arm pain in injection arm on day 1.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP), high cholesterol, and penicillin allergy. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), lamotrigine (LAMICTAL), cyanocobalamin (B12), cholecalciferol (D3), magnesium (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) all taken for an unknown indication and from an unknown date. The patient previously received codeine for an unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG200), via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced extreme arm pain in injection arm on day 1. On 01Apr2021, on day 2 the patient experienced fever of 101 degrees Fahrenheit (F), severe chills, body aches and skin tenderness. It was reported that the symptoms had been lasted for approximately 24 hours. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcomes of the events extreme arm pain in injection arm, fever, severe chills, body aches and skin tenderness were recovered on an unknown date (reported as lasted for approximately 24 hours (in 2021)).   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Day 2 fever of 101 degrees F; severe chills; body aches; skin tenderness; Extreme arm pain in injection arm on day 1.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP), high cholesterol, and penicillin allergy. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), lamotrigine (LAMICTAL), cyanocobalamin (B12), cholecalciferol (D3), magnesium (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) all taken for an unknown indication and from an unknown date. The patient previously received codeine for an unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG200), via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced extreme arm pain in injection arm on day 1. On 01Apr2021, on day 2 the patient experienced fever of 101 degrees Fahrenheit (F), severe chills, body aches and skin tenderness. It was reported that the symptoms had been lasted for approximately 24 hours. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcomes of the events extreme arm pain in injection arm, fever, severe chills, body aches and skin tenderness were recovered on an unknown date (reported as lasted for approximately 24 hours (in 2021)).   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Hypertension, Nausea, Night sweats
Clinical narrative: Intolerance to heat; Night sweats; Stomach upset; High blood pressure; Nausea; Chills; Slept all day; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: LAB-1451-0.7) via an unspecified route of administration in the left arm on 23Mar2021 at 14:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, prehypertension, anxiety, diverticulum, ulcers, vertigo, shingles, palpitations, herpes simplex type 1 and 2, gastroesophageal reflux disease (GERD) and hiatal hernia. The patient had received other unspecified medications within 2 weeks of vaccination. The patient previously took codeine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the day of vaccination the patient slept all day. On 30Mar2021 at 13:00, day 7 after vaccination, the patient experienced intolerance to heat, night sweats, nausea, stomach upset, chills and high blood pressure. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome slept all day, intolerance to heat, night sweats, nausea, stomach upset, chills and high blood pressure were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Temperature intolerance
Clinical narrative: Intolerance to heat; Night sweats; Stomach upset; High blood pressure; Nausea; Chills; Slept all day; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: LAB-1451-0.7) via an unspecified route of administration in the left arm on 23Mar2021 at 14:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, prehypertension, anxiety, diverticulum, ulcers, vertigo, shingles, palpitations, herpes simplex type 1 and 2, gastroesophageal reflux disease (GERD) and hiatal hernia. The patient had received other unspecified medications within 2 weeks of vaccination. The patient previously took codeine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the day of vaccination the patient slept all day. On 30Mar2021 at 13:00, day 7 after vaccination, the patient experienced intolerance to heat, night sweats, nausea, stomach upset, chills and high blood pressure. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome slept all day, intolerance to heat, night sweats, nausea, stomach upset, chills and high blood pressure were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Heart rate, Heart rate increased
Clinical narrative: chest discomfort; Felt like fast heart rate at times; chills; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the left arm on 26Mar2021 at 19:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3302), via an unspecified route of administration in the left arm on 05Mar2021 at 19:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 05:30, the patient experienced like fast heart rate at times, chills, tiredness, chest discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of fast heart rate, chills, tiredness and chest discomfort were recovered with sequelae.    No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fatigue; Upset stomach; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA), COVID-19 and NSAIDS drug allergy. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and hydroxychloroquine phosphate (PLAQUENIL) for unknown indication on unknown dates within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. On 25Feb2021, the patient underwent COVID-19 virus teat (nasal swab) and the result was negative. Since the vaccination, the patient had been tested for COVID-19 with result unknown. On 31Mar2021 at 12:00 the patient experienced upset stomach and low-grade fever. On day 2, 01-Apr-2021, the patient experienced fatigue. Therapeutic treatment received for the reported event low-grade fever was TYLENOL but the event was continuing. The patient did not receive any treatment for the events upset stomach and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events upset stomach, low-grade fever and fatigue were not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Polymenorrhoea
Clinical narrative: Period started within an hour of the shot (one week earlier than expected); Overwhelming exhaustion (slept all day); Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021 at 14:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, asthma, post-traumatic stress disorder (PTSD) and irritable bowel syndrome (IBS). The patient was allergic to sulfas, eggs, sesame seeds and shrimp. Concomitant medications included duloxetine hydrochloride (DULOXETINE), beclometasone dipropionate (QVAR), salbutamol (ALBUTEROL), magnesium (MANUFACTURER UNKNOWN), and iron (MANUFACTURER UNKNOWN) all from an unspecified date used for unknown indication. The patient previously took iodine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 15:00, the patient had period within an hour of the shot. The period had occurred one week earlier than expected. On an unknown date in 2021, the patient experienced overwhelming exhaustion (slept all day) and sore arm. The patient did not receive any treatment for the events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the overwhelming exhaustion (slept all day), sore arm and period started within an hour of the shot (one week earlier than expected) was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Vertigo
Clinical narrative: Extreme dizziness; Vertigo symptoms; Nausea; Mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 18Mar2021 at 12:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included newly diagnosed diabetes in Jan2021, high cholesterol. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had allergy to medicine with sulfa. Concomitant medications included metformin (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR), berberine (MANUFACTURER UNKNOWN) chromium (MANUFACTURER UNKNOWN) and trigonella foenum-graecum (FENUGREEK) all since an unknown date for unknown indication. Since vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 23:15, within 11 hours after vaccination the patient experienced extreme dizziness and vertigo symptoms. Upon laying down, the room would spin for 20 seconds and when showering room was spinning. The patient also experienced nausea and mild headache after dizziness episodes. These events occurred multiple times daily with 72 hours of time period. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the extreme dizziness, vertigo symptoms, nausea and mild headache were resolved on 21Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Left arm injection site/ Intense stabbing pain; Unable to lift left arm up past 90 degrees; This is a spontaneous report from a contactable healthcare professional, the patient.   A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 09:15 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included the patient to be generally healthy. The patient was allergic to latex. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) 40 mg QOD, cholecalciferol (VIT D) 5000IU QD, and multivitamins (MANUFACTURER UNKNOWN) QD on unknown dates for unspecified indications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 11:15 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021 at 16:00 the patient experienced intense stabbing pain on left arm injection site approximately 10 hours after, no heat and redness at felt at injection site and unable to lift left arm up past 90 degrees. Intense pain lasted all night and most of next morning. The patient reported the pain to be at 10 with movement in the scale of 1 to 10. Therapeutic measures included treatment with TYLENOL and SALONPAS for intense stabbing pain on the left arm injection site and unable to lift left arm. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome for the events vaccination site pain and pain upon movement were recovering.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Computerised tomogram, Ear pain, Facial pain, Migraine
Clinical narrative: Ear pain; Vertigo; Facial pain/freezing pain; Ear noise/Tinnitus/continuing sounds like water in right ear; Facial pain -burning; Ear pain and noise -escalating to Migraines; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the right arm on 04Feb2021 at 07:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included numerous autoimmune issues, drug allergy (allergy to versed, codeine, morphine, cymbalta and nitrous oxide) and latex allergy. The patient received unspecified medication for unknown indications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks of vaccination. The past drug history included codeine, versed, morphine, cymbalta and nitrous oxide had taken from on unspecified date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Feb2021 at 09:00 the patient experienced ear pain, vertigo, facial pain/freezing pain, ear noise/continuing sounds like water in right ear, tinnitus, facial pain -burning and ear pain and noise -escalating to migraines. It was reported that the events had resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events included PT (physical therapy) which was ongoing and the patient was referred to specialist. On an unknown date, the patient underwent CT (computed tomography) sinus and the result was unknown. The clinical outcome of the events ear pain, tinnitus, vertigo, facial pain/freezing pain, ear noise/continuing sounds like water in right ear, facial pain -burning and ear pain and noise -escalating to migraines was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: Ear pain; Vertigo; Facial pain/freezing pain; Ear noise/Tinnitus/continuing sounds like water in right ear; Facial pain -burning; Ear pain and noise -escalating to Migraines; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the right arm on 04Feb2021 at 07:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included numerous autoimmune issues, drug allergy (allergy to versed, codeine, morphine, cymbalta and nitrous oxide) and latex allergy. The patient received unspecified medication for unknown indications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks of vaccination. The past drug history included codeine, versed, morphine, cymbalta and nitrous oxide had taken from on unspecified date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Feb2021 at 09:00 the patient experienced ear pain, vertigo, facial pain/freezing pain, ear noise/continuing sounds like water in right ear, tinnitus, facial pain -burning and ear pain and noise -escalating to migraines. It was reported that the events had resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events included PT (physical therapy) which was ongoing and the patient was referred to specialist. On an unknown date, the patient underwent CT (computed tomography) sinus and the result was unknown. The clinical outcome of the events ear pain, tinnitus, vertigo, facial pain/freezing pain, ear noise/continuing sounds like water in right ear, facial pain -burning and ear pain and noise -escalating to migraines was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Headache, Memory impairment, Post concussion syndrome
Clinical narrative: Post concussive symptoms; headache; trouble multi-tasking; difficulty remembering sequence in routinetasks.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 28Mar2021(at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included concussion and post-concussion syndrome. Concomitant medications included minerals nos, vitamins nos (ONE A DAY VITAMIN) from unknown date for unknown indication. The patient was having allergy to hydrocodone. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration on right arm on 07Mar2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 29Mar2021 the patient experienced post concussive symptoms including a headache, trouble multi-tasking and difficulty remembering sequence in routine tasks.  The patient reported that she had experienced a concussion about 18Feb2020. Post concussive symptoms continued for about 6 months after. After the second vaccination, she experienced similar post concussive symptoms including a headache, trouble multi-tasking, difficulty remembering sequence in routine tasks. The clinical outcome of the events post concussive symptoms, headache, trouble multi-tasking and difficulty remembering sequence in routine were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Headache, Malaise
Clinical narrative: Fatigue; Low grade headache; General icky feeling; Intermittent shortness of breath.; Chills; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 12:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included severe iron deficient anemia and COVID-19 (COVID 4 mos). The patient did not have allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 the patient experienced chills about 5-9 at night followed by fatigue about 9-2 AM. Six days later still have low grade headache, general icky feeling, and intermittent shortness of breath. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the event chills was recovered on 29Mar2021 at 21:00 and fatigue was recovered on 30Mar2021 at 02:00 while the outcomes of low grade headache, general icky feeling, and intermittent shortness of breath was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Myalgia, Pyrexia, Tremor
Clinical narrative: High fever; Chills; Shaking; Extreme muscle pain; Painful swollen lymph node in armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Apr2021 at 08:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 20:00, the patient experienced shaking, high fever, chills, extreme muscle pain and painful swollen lymph node in armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events shaking, high fever, chills, extreme muscle pain and painful swollen lymph node in armpit was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in armpit and back of neck on right side.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 31Mar2021 at 15:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to codeine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on 10Mar2021(at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 00:00, the patient experienced very swollen lymph nodes in armpit and back of neck on right side. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events.  The clinical outcome of the event swollen lymph nodes in armpit and back of neck on right side was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed, Pregnancy test
Clinical narrative: Have not have a period since February and I am late.; This is a spontaneous report received from a contactable nurse, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on 25Feb2021 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 04Feb2021 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 03Mar2021, the patient experienced late and did not had a period since February. The patient never been late on period in the life. Negative pregnancy tests. The adverse events result in a visit to the doctors or other healthcare professional office/clinic visit. The patient did not receive any treatment for late period. The clinical outcome of the event late period was not resolved at the time of the report.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Extreme nausea; vomiting; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 30Mar2021 at 12:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Mar2021, the patient experienced extreme nausea and vomiting for 04 days. The patient did not receive treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme nausea and vomiting was resolving at the time of report.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchy arms; Itchy legs; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Mar2021 at 09:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient received other medication in 2 weeks which included atorvastatin (MANUFACTURER UNKNOWN) for unknown indication and start date. Patient reported unspecified allergy to food, medication and other products. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 23Mar2021 at unknown time, the patient experienced itchy arms and itchy legs after three days of vaccination. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events itchy arms and itchy legs were recovered on unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles 3 days later.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 at 19:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination; the patient was diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient had not been tested for COVID-19. On 27Mar2021 at 20:00, 3 days after receiving the vaccine the patient developed Shingles. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for the reported event and included treatment with viral medication. The clinical outcome of the event Shingles was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: Swelling under left arm, assume it is lymph nodes; Sore left side neck/Trapezius muscles; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 13:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included gout and hypertension. The patient was allergic to allopurinol (MANUFACTURER UNKNOWN). Concomitant medication included febroxitone (MANUFACTURER UNKNOWN) for gout and irebesartan (MANUFACTURER UNKNOWN) for blood pressure. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Mar2021 at 13:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:30, the patient experienced swelling under left arm, he assumed it was lymph nodes and sore left side neck/Trapezius muscles. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swelling under left arm, assumed it was lymph nodes and sore left side neck/trapezius muscles was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Body temperature increased, Myalgia, Vaccination site pain
Clinical narrative: Site injection tenderness; Arm muscle soreness; Shoulder/hip joint soreness; Slightly elevated temperature about 12 to 24 hr post administration; This is a spontaneous report from a contactable consumer, the patient. A 58 year old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 09:30 as a single dose for COVID-19 immunisation. Medical history included right hip replacement and bilateral frozen shoulder for which patient was receiving physical therapy. The patient had gluten food sensitivity. Concomitant medication included cetirizine hydrochloride (ZYRTEC) and daily vitamin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 09:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 22:00, the patient experienced  injection site tenderness, muscle soreness and shoulder or hip joint soreness. On an unknown date in 2021, about 12 to 24 hours post vaccination, the patient experienced slightly elevated temperature. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient received treatment with TYLENOL post 24 hour of vaccination for the reported events. Th event of elevated temperature resolved after receiving the treatment with TYLENOL. The clinical outcome of the events site injection tenderness, arm muscle soreness, shoulder or hip joint soreness and slightly elevated temperature was recovered on an unspecified date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm.; Tired; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received her unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. On an unknown date the patient experienced sore arm and was tired. There was no information on whether the events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore arm and tired were unknown at the time of the report.  Information about the lot number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat; ear pain; fever; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm  on 31Mar2021 at 09:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and high blood pressure. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 20:00,  the patient experienced sore throat, fever and ear pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of sore throat, fever and  ear pain were unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue
Clinical narrative: Diarrhea within 72 hours after vaccination; Tiredness accompanying diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 10:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 08:00, within 72 hours after vaccination, the patient experienced diarrhea and tiredness accompanying diarrhea. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events diarrhea and tiredness accompanying diarrhea was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Headache on the lower right side of head; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the left arm on 31Mar2021 at 14:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, blood pressure high and arthritis. Concomitant medications included hydrochlorothiazide (+) olmesartan medoxomil (OLMESARTAN HCTZ), glimepiride (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient was not allergic to food, medication or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 16:00, the patient experienced sore arm (pain in arm) and headache on the lower right side of head. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcomes of the event sore arm headache on the lower right side of head were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Headache
Clinical narrative: Back ache; Headache; Joint pain; Tired; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 31Mar2021 at 17:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included ADD (attention deficit disorder), lichen planus and asthma. No allergies to medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and doxycycline (MANUFACTURER UNKNOWN) both on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm left on 10Mar2021 at 17:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 15:30 the patient experienced back ache, headache, joint pain and tired. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event back ache, headache, joint pain and tired was recovering.   No follow-up attempts are needed. No further information is expected.